KURE ETF — KraneShares MSCI All China Health Care Index ETF

KraneShares MSCI All China Health Care Index ETF (KURE)

Updated October 16, 2026.

KURE is an ETF. its distribution rate is 1.04%, its trailing-12-month yield is 4.05%, its expense ratio is 0.65%. Dividend Vision Distribution Safety Score™ is 44/100 (Caution). Total return is -12.9% over the past 8.7 years, 222.4 points behind SPY at 209.5%.

KraneShares MSCI All China Health Care Index ETF tracks a free float-adjusted market capitalization weighted index of Chinese healthcare companies, investing at least 80% of its assets in index components or economically similar instruments. The fund distributes annually at a modest current rate with an expense ratio of 0.65%; note that its latest distribution was special and may not recur on a regular basis. The ETF appeals to investors seeking exposure to China's healthcare sector through a passive index strategy.

KURE performance versus SPY

Price and return data through 2026-10-16.

Total return is -12.9% over the past 8.7 years, 222.4 points behind SPY at 209.5%. Over the past year its total return — price change plus distributions reinvested — is -7.4%. Its deepest 1-year drawdown was 24.6%.

KURE key facts

Distribution Safety Score™

44 · Caution

Safety-Adjusted Yield

0.46%

Issuer

KraneShares

Asset type

ETF

Asset class

Equity

Inception date

01/31/2018

Expense ratio

0.65%

Distribution rate

1.04%

Distribution frequency

Annual

Trailing yield

4.05%

Last close

$17.65 (as of 2026-10-16)

AUM

$114,285,238

Average volume

19068.0

Dividend

$0.715

Ex-dividend date

12/22/2025

Payment date

12/23/2025

Beta

0.34

How Dividend Vision calculates yield and returns

Distribution rate (1.04%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (4.05%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: KraneShares; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

KURE risks and drawbacks

KURE's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 24.6%.

Who may consider KURE — and who may not

It is a weaker fit for investors who need monthly cash flow (KURE pays annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on KURE

• All tickers starting with K

Tagged: Healthcare, International, Index.

Frequently asked questions

More securities from KraneShares.